Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3520LO1M
Performance in the last:
Follow this Portfolio
1D -0.1 %
1W 0.4 %
2W 0.0 %
1M -1.3 %
3M -0.3 %
6M 4.0 %
9M 10.2 %
1Y 17.3 %
Alpha
-2.1%
Beta
0.63
sharpe-R
0.9
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
2.97
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2024-10-18 07:52:18
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -9.49%
Max. DrawDown Benchmark -8.41%

This Long Only strategy aims to find promising assets to invest in for a maximum holding period of 1 Month in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 20.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
2
Difficulty Level
2

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 5.1% 4.23%
ORGO Organogenesis Holdings Inc. Buy 4.88% -0.32%
ARDX Ardelyx, Inc. Buy 4.71% -3.48%
BKD Brookdale Senior Living Inc. Buy 5.33% 9.26%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 5.25% 7.64%
VCEL Vericel Corporation Buy 4.72% -3.37%
CDXS Codexis, Inc. Buy 4.85% -0.59%
SGMO Sangamo Therapeutics, Inc. Buy 4.73% -3.09%
VREX Varex Imaging Corporation Buy 4.87% 0%
NKTR Nektar Therapeutics Buy 4.87% 0%
LXRX Lexicon Pharmaceuticals, Inc. Buy 4.87% 0%
AXSM Axsome Therapeutics, Inc. Buy 4.87% 0%
The percentage of cash held in the portfolio is: 40.94%
** The description of each asset is available Here

The latest 5 Compositions change

2024-10-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 5.1% 4.23%
ORGO Organogenesis Holdings Inc. Buy 4.88% -0.32%
ARDX Ardelyx, Inc. Buy 4.71% -3.48%
BKD Brookdale Senior Living Inc. Buy 5.33% 9.26%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 5.25% 7.64%
VCEL Vericel Corporation Buy 4.72% -3.37%
CDXS Codexis, Inc. Buy 4.85% -0.59%
SGMO Sangamo Therapeutics, Inc. Buy 4.73% -3.09%
VREX Varex Imaging Corporation Buy 4.87% 0%
NKTR Nektar Therapeutics Buy 4.87% 0%
LXRX Lexicon Pharmaceuticals, Inc. Buy 4.87% 0%
AXSM Axsome Therapeutics, Inc. Buy 4.87% 0%
The percentage of cash held in the portfolio is: 40.94%
New Assets Added
  • VREX
  • NKTR
  • LXRX
  • AXSM
Assets Removed
Asset Action Perf %
RDNT Sell All -3.2%
Assets Rebalanced
None
2024-10-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 5.04% 3.05%
ORGO Organogenesis Holdings Inc. Buy 5.08% 3.9%
ARDX Ardelyx, Inc. Buy 4.82% -1.16%
BKD Brookdale Senior Living Inc. Buy 4.89% 0.33%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 5.01% 2.69%
VCEL Vericel Corporation Buy 4.86% -0.33%
RDNT RadNet, Inc. Buy 4.89% 0.2%
CDXS Codexis, Inc. Buy 4.88% 0%
SGMO Sangamo Therapeutics, Inc. Buy 4.88% 0%
The percentage of cash held in the portfolio is: 55.65%
New Assets Added
  • CDXS
  • SGMO
Assets Removed
None
Assets Rebalanced
None
2024-10-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 4.95% 0.7%
ORGO Organogenesis Holdings Inc. Buy 4.93% 0.32%
ARDX Ardelyx, Inc. Buy 4.86% -0.83%
BKD Brookdale Senior Living Inc. Buy 4.9% 0%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 4.9% 0%
VCEL Vericel Corporation Buy 4.9% 0%
RDNT RadNet, Inc. Buy 4.9% 0%
The percentage of cash held in the portfolio is: 65.67%
New Assets Added
  • BKD
  • ARWR
  • VCEL
  • RDNT
Assets Removed
None
Assets Rebalanced
None
2024-10-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 4.92% 0%
ORGO Organogenesis Holdings Inc. Buy 4.9% -0.32%
ARDX Ardelyx, Inc. Buy 4.9% 0%
The percentage of cash held in the portfolio is: 85.29%
New Assets Added
  • ARDX
Assets Removed
None
Assets Rebalanced
None
2024-10-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 4.86% -1.17%
ORGO Organogenesis Holdings Inc. Buy 4.83% -1.95%
The percentage of cash held in the portfolio is: 90.31%
New Assets Added
None
Assets Removed
Asset Action Perf %
BCRX Sell All -6.07%
Assets Rebalanced
None
2024-10-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 4.94% 0.94%
BCRX BioCryst Pharmaceuticals, Inc. Buy 4.9% 0%
ORGO Organogenesis Holdings Inc. Buy 4.9% 0%
The percentage of cash held in the portfolio is: 85.26%
New Assets Added
  • BCRX
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-10-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 4.9% 0%
The percentage of cash held in the portfolio is: 95.1%
New Assets Added
  • IRWD
Assets Removed
None
Assets Rebalanced
None
2024-09-30 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
PODD Sell All 13.51%
Assets Rebalanced
None
2024-09-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 5.83% 16.82%
The percentage of cash held in the portfolio is: 94.17%
New Assets Added
None
Assets Removed
Asset Action Perf %
AADI Sell All 8.57%
NVCR Sell All -11.63%
Assets Rebalanced
None
2024-09-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 5.35% 8%
PODD Insulet Corporation Buy 5.83% 16.92%
NVCR NovoCure Limited Buy 4.38% -8.98%
The percentage of cash held in the portfolio is: 84.45%
New Assets Added
None
Assets Removed
Asset Action Perf %
MYGN Sell All -1.56%
Assets Rebalanced
None
2024-09-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 5.4% 9.14%
PODD Insulet Corporation Buy 5.82% 16.9%
NVCR NovoCure Limited Buy 4.4% -8.42%
MYGN Myriad Genetics, Inc. Buy 4.75% -0.15%
The percentage of cash held in the portfolio is: 79.64%
New Assets Added
None
Assets Removed
Asset Action Perf %
ESPR Sell All -10.93%
Assets Rebalanced
None
2024-09-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 5.42% 10.29%
PODD Insulet Corporation Buy 5.73% 15.73%
ESPR Esperion Therapeutics, Inc. Buy 4.55% -8.2%
NVCR NovoCure Limited Buy 4.62% -3.32%
MYGN Myriad Genetics, Inc. Buy 4.85% 2.48%
The percentage of cash held in the portfolio is: 74.83%
New Assets Added
None
Assets Removed
Asset Action Perf %
AGEN Sell All 6.76%
Assets Rebalanced
None
2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
AGEN Agenus Inc. Buy 5.45% 11.15%
AADI Aadi Bioscience, Inc. Buy 5.26% 7.43%
PODD Insulet Corporation Buy 5.65% 14.42%
ESPR Esperion Therapeutics, Inc. Buy 4.74% -3.83%
NVCR NovoCure Limited Buy 4.73% -0.5%
MYGN Myriad Genetics, Inc. Buy 4.87% 3.45%
The percentage of cash held in the portfolio is: 69.29%
New Assets Added
None
Assets Removed
Asset Action Perf %
MGNX Sell All -2.28%
APLS Sell All -8.89%
TVTX Sell All 48.65%
Assets Rebalanced
None
2024-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 4.9% -1.69%
AGEN Agenus Inc. Buy 4.98% -0.18%
AADI Aadi Bioscience, Inc. Buy 5.07% 1.71%
PODD Insulet Corporation Buy 5.56% 10.8%
MGNX MacroGenics, Inc. Buy 5.09% 1.42%
ESPR Esperion Therapeutics, Inc. Buy 4.74% -5.46%
TVTX Travere Therapeutics, Inc. Buy 6.6% 33.75%
NVCR NovoCure Limited Buy 4.53% -6.37%
MYGN Myriad Genetics, Inc. Buy 4.81% 0.26%
The percentage of cash held in the portfolio is: 53.72%
New Assets Added
None
Assets Removed
Asset Action Perf %
CARA Sell All -18.08%
Assets Rebalanced
None
2024-09-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.01% 0.21%
CARA Cara Therapeutics, Inc. Buy 4.52% -9.62%
AGEN Agenus Inc. Buy 4.69% -6.22%
AADI Aadi Bioscience, Inc. Buy 5.16% 3.43%
PODD Insulet Corporation Buy 5.39% 7.2%
MGNX MacroGenics, Inc. Buy 4.94% -1.71%
ESPR Esperion Therapeutics, Inc. Buy 4.67% -7.1%
TVTX Travere Therapeutics, Inc. Buy 6.62% 33.96%
NVCR NovoCure Limited Buy 4.46% -7.98%
MYGN Myriad Genetics, Inc. Buy 4.83% 0.63%
The percentage of cash held in the portfolio is: 49.72%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALDX Sell All -6.49%
Assets Rebalanced
None
2024-09-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.2% 3%
CARA Cara Therapeutics, Inc. Buy 4.74% -6.12%
AGEN Agenus Inc. Buy 4.57% -9.51%
AADI Aadi Bioscience, Inc. Buy 5.28% 4.57%
PODD Insulet Corporation Buy 5.34% 5.05%
MGNX MacroGenics, Inc. Buy 4.71% -7.41%
ESPR Esperion Therapeutics, Inc. Buy 4.58% -9.84%
TVTX Travere Therapeutics, Inc. Buy 5.71% 14.37%
ALDX Aldeyra Therapeutics, Inc. Buy 4.75% -3.01%
NVCR NovoCure Limited Buy 4.58% -6.48%
MYGN Myriad Genetics, Inc. Buy 4.85% 0%
The percentage of cash held in the portfolio is: 45.68%
New Assets Added
  • MYGN
Assets Removed
Asset Action Perf %
ORGO Sell All -12.72%
Assets Rebalanced
None
2024-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 4.96% -1.42%
ORGO Organogenesis Holdings Inc. Buy 4.69% -6.71%
CARA Cara Therapeutics, Inc. Buy 4.71% -6.41%
AGEN Agenus Inc. Buy 4.6% -8.59%
AADI Aadi Bioscience, Inc. Buy 5.17% 2.86%
PODD Insulet Corporation Buy 5.35% 5.72%
MGNX MacroGenics, Inc. Buy 4.88% -3.7%
ESPR Esperion Therapeutics, Inc. Buy 4.76% -6.01%
TVTX Travere Therapeutics, Inc. Buy 5.15% 3.44%
ALDX Aldeyra Therapeutics, Inc. Buy 4.88% 0%
NVCR NovoCure Limited Buy 4.88% 0%
The percentage of cash held in the portfolio is: 45.96%
New Assets Added
  • NVCR
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 4.77% -5.21%
ORGO Organogenesis Holdings Inc. Buy 4.8% -4.59%
CARA Cara Therapeutics, Inc. Buy 4.73% -6.12%
AGEN Agenus Inc. Buy 4.46% -11.33%
AADI Aadi Bioscience, Inc. Buy 5.18% 2.86%
PODD Insulet Corporation Buy 5.27% 3.96%
MGNX MacroGenics, Inc. Buy 4.79% -5.41%
ESPR Esperion Therapeutics, Inc. Buy 5.04% -0.55%
TVTX Travere Therapeutics, Inc. Buy 5.21% 4.69%
ALDX Aldeyra Therapeutics, Inc. Buy 4.89% 0%
The percentage of cash held in the portfolio is: 50.87%
New Assets Added
  • ALDX
Assets Removed
Asset Action Perf %
CERS Sell All -11.34%
EGRX Sell All -11.35%
Assets Rebalanced
None
2024-09-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 4.9% -2.65%
ORGO Organogenesis Holdings Inc. Buy 4.85% -3.53%
CARA Cara Therapeutics, Inc. Buy 4.86% -3.5%
AGEN Agenus Inc. Buy 4.55% -9.51%
CERS Cerus Corporation Buy 4.63% -7.98%
AADI Aadi Bioscience, Inc. Buy 5% -0.57%
PODD Insulet Corporation Buy 5.12% 1.11%
EGRX Eagle Pharmaceuticals, Inc. Buy 4.54% -10.38%
MGNX MacroGenics, Inc. Buy 4.73% -6.55%
ESPR Esperion Therapeutics, Inc. Buy 5.06% 0%
TVTX Travere Therapeutics, Inc. Buy 4.98% 0%
The percentage of cash held in the portfolio is: 46.78%
New Assets Added
  • TVTX
Assets Removed
Asset Action Perf %
ARDX Sell All -11.62%
NEOG Sell All -6.34%
Assets Rebalanced
None
2024-09-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 4.75% -2.98%
APLS Apellis Pharmaceuticals, Inc. Buy 4.78% -2.4%
ORGO Organogenesis Holdings Inc. Buy 4.99% 1.77%
CARA Cara Therapeutics, Inc. Buy 5.14% 4.96%
AGEN Agenus Inc. Buy 4.61% -5.85%
CERS Cerus Corporation Buy 4.65% -5.04%
AADI Aadi Bioscience, Inc. Buy 5.06% 3.43%
NEOG Neogen Corporation Buy 4.95% 0.35%
PODD Insulet Corporation Buy 4.89% -0.81%
EGRX Eagle Pharmaceuticals, Inc. Buy 4.87% -1.15%
MGNX MacroGenics, Inc. Buy 4.93% 0%
ESPR Esperion Therapeutics, Inc. Buy 4.93% 0%
The percentage of cash held in the portfolio is: 41.44%
New Assets Added
  • MGNX
  • ESPR
Assets Removed
None
Assets Rebalanced
None
2024-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 4.76% -3.45%
APLS Apellis Pharmaceuticals, Inc. Buy 4.72% -4.2%
ORGO Organogenesis Holdings Inc. Buy 5.1% 3.53%
CARA Cara Therapeutics, Inc. Buy 5.11% 3.79%
AGEN Agenus Inc. Buy 4.6% -6.58%
CERS Cerus Corporation Buy 4.63% -5.88%
AADI Aadi Bioscience, Inc. Buy 4.73% -4%
NEOG Neogen Corporation Buy 4.85% -2.15%
PODD Insulet Corporation Buy 4.96% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 4.96% 0%
The percentage of cash held in the portfolio is: 51.58%
New Assets Added
  • PODD
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 4.76% -2.35%
APLS Apellis Pharmaceuticals, Inc. Buy 4.84% -0.64%
ORGO Organogenesis Holdings Inc. Buy 5.06% 3.89%
CARA Cara Therapeutics, Inc. Buy 5.1% 4.66%
AGEN Agenus Inc. Buy 5.02% 2.93%
CERS Cerus Corporation Buy 4.75% -2.52%
AADI Aadi Bioscience, Inc. Buy 4.68% -4%
NEOG Neogen Corporation Buy 4.91% 0%
The percentage of cash held in the portfolio is: 60.87%
New Assets Added
  • NEOG
Assets Removed
Asset Action Perf %
CYH Sell All 4.72%
Assets Rebalanced
None
2024-08-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 5.3% 6.09%
ARDX Ardelyx, Inc. Buy 4.78% -0.94%
APLS Apellis Pharmaceuticals, Inc. Buy 4.82% -0.05%
ORGO Organogenesis Holdings Inc. Buy 5.17% 7.07%
CARA Cara Therapeutics, Inc. Buy 5.21% 7.87%
AGEN Agenus Inc. Buy 5.18% 7.31%
CERS Cerus Corporation Buy 4.82% 0%
AADI Aadi Bioscience, Inc. Buy 4.82% 0%
The percentage of cash held in the portfolio is: 59.89%
New Assets Added
  • CERS
  • AADI
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 4.88% -4.32%
ARDX Ardelyx, Inc. Buy 4.68% -5.02%
APLS Apellis Pharmaceuticals, Inc. Buy 4.84% -1.79%
ORGO Organogenesis Holdings Inc. Buy 4.79% -2.83%
CARA Cara Therapeutics, Inc. Buy 4.93% 0%
AGEN Agenus Inc. Buy 4.93% 0%
The percentage of cash held in the portfolio is: 70.97%
New Assets Added
  • CARA
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 4.92% -2.95%
ARDX Ardelyx, Inc. Buy 4.9% 0%
APLS Apellis Pharmaceuticals, Inc. Buy 4.9% 0%
ORGO Organogenesis Holdings Inc. Buy 4.9% 0%
The percentage of cash held in the portfolio is: 80.38%
New Assets Added
  • ARDX
  • APLS
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-08-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 4.99% -1.57%
The percentage of cash held in the portfolio is: 95.01%
New Assets Added
None
Assets Removed
Asset Action Perf %
RCM Sell All 7.37%
Assets Rebalanced
None
2024-08-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 4.74% 7.37%
CYH Community Health Systems, Inc. Buy 4.82% -4.91%
The percentage of cash held in the portfolio is: 90.44%
New Assets Added
None
Assets Removed
Asset Action Perf %
OPK Sell All 13.64%
ANGO Sell All 21.37%
SGRY Sell All 16.4%
AVNS Sell All 6.33%
RGNX Sell All -8.1%
SUPN Sell All 12.67%
Assets Rebalanced
None
2024-08-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 4.38% -3.03%
ANGO AngioDynamics, Inc. Buy 5.32% 17.78%
SGRY Surgery Partners, Inc. Buy 5.05% 11.98%
AVNS Avanos Medical, Inc. Buy 4.79% 6.19%
RGNX REGENXBIO Inc. Buy 4.28% -5.27%
SUPN Supernus Pharmaceuticals, Inc. Buy 5.06% 12.04%
RCM R1 RCM Inc. Buy 4.78% 7.14%
CYH Community Health Systems, Inc. Buy 4.74% -7.66%
The percentage of cash held in the portfolio is: 61.6%
New Assets Added
None
Assets Removed
Asset Action Perf %
RMD Sell All 1.39%
Assets Rebalanced
None
2024-08-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
OPK OPKO Health, Inc. Buy 4.48% -0.76%
ANGO AngioDynamics, Inc. Buy 5.5% 22.02%
SGRY Surgery Partners, Inc. Buy 5.07% 12.41%
AVNS Avanos Medical, Inc. Buy 4.88% 8.36%
RGNX REGENXBIO Inc. Buy 4.44% -1.57%
SUPN Supernus Pharmaceuticals, Inc. Buy 4.42% -2%
RCM R1 RCM Inc. Buy 4.77% 7.06%
CYH Community Health Systems, Inc. Buy 4.85% -5.3%
RMD ResMed Inc. Buy 4.77% 3.67%
The percentage of cash held in the portfolio is: 56.83%
New Assets Added
None
Assets Removed
Asset Action Perf %
PDSB Sell All -10.51%
MASI Sell All -6.4%
Assets Rebalanced
None
2024-08-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 4.07% -8.52%
OPK OPKO Health, Inc. Buy 4.55% 2.27%
ANGO AngioDynamics, Inc. Buy 5.63% 26.75%
SGRY Surgery Partners, Inc. Buy 5.05% 13.78%
AVNS Avanos Medical, Inc. Buy 5.03% 13.36%
RGNX REGENXBIO Inc. Buy 4.56% 2.6%
SUPN Supernus Pharmaceuticals, Inc. Buy 4.49% 1.02%
MASI Masimo Corporation Buy 4.19% -5.02%
RCM R1 RCM Inc. Buy 4.73% 7.83%
CYH Community Health Systems, Inc. Buy 4.95% -1.96%
RMD ResMed Inc. Buy 4.88% 7.5%
The percentage of cash held in the portfolio is: 47.89%
New Assets Added
None
Assets Removed
Asset Action Perf %
CUTR Sell All -19.59%
HQY Sell All -11.82%
SAVA Sell All 95.11%
SAGE Sell All -12.65%
HCSG Sell All -6.49%
Assets Rebalanced
None
2024-08-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 4.1% -8.24%
OPK OPKO Health, Inc. Buy 4.67% 4.55%
ANGO AngioDynamics, Inc. Buy 5.68% 27.08%
SGRY Surgery Partners, Inc. Buy 5.28% 18.28%
AVNS Avanos Medical, Inc. Buy 5.01% 12.13%
CUTR Cutera, Inc. Buy 3.92% -12.16%
RGNX REGENXBIO Inc. Buy 4.68% 4.72%
SUPN Supernus Pharmaceuticals, Inc. Buy 4.64% 3.79%
MASI Masimo Corporation Buy 4.25% -4.14%
RCM R1 RCM Inc. Buy 4.79% 8.44%
CYH Community Health Systems, Inc. Buy 5% -1.57%
HQY HealthEquity, Inc. Buy 4.88% -3.84%
SAVA Cassava Sciences, Inc. Buy 8% 57.44%
SAGE Sage Therapeutics, Inc. Buy 4.51% -11.19%
HCSG Healthcare Services Group, Inc. Buy 4.21% -3.72%
RMD ResMed Inc. Buy 4.71% 3.13%
The percentage of cash held in the portfolio is: 21.66%
New Assets Added
None
Assets Removed
Asset Action Perf %
FATE Sell All -12.39%
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings